Clinical Trial Update: PCI for Patients With ES-SCLC After RCT:a Prospective Randomized Study [Phase 3]

View source ↗

Summary

A Phase 3 randomized study evaluating PCI for patients with extensive-stage small-cell lung cancer following a prior randomized trial.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Snippet

Sponsor: Chinese Academy of Medical Sciences | Conditions: Small-cell Lung Cancer | Phase 3 | Status: UNKNOWN